ORF57 overcomes the detrimental sequence bias of Kaposi's sarcoma-associated herpesvirus lytic genes

Journal of Virology

Volumn 89, Issue 9, 2015, Pages 5097-5109

  Vogt, Carolin ^a   Hackmann, Christian ^a,c   Rabner, Alona ^b   Koste, Lars ^a,d   Santag, Susann ^a   Kati, Semra ^a   Mandel Gutfreund, Yael ^b   Schulz, Thomas F ^a   Bohne, Jens ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c BIELEFELD UNIVERSITY   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; COMPLEMENTARY DNA; CYTOSINE; GAG PROTEIN; GUANINE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; MESSENGER RNA; PROTEIN ORF57; REV PROTEIN; RNA BINDING PROTEIN; THYMINE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; ORF57 PROTEIN, HUMAN HERPESVIRUS 8; PROTEIN BINDING;

ARTICLE; AT RICH SEQUENCE; BIOINFORMATICS; CELL NUCLEUS; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; HUMAN HERPESVIRUS 8; INTRON; K15 GENE; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE MOTIF; NUCLEOTIDE SEQUENCE; NUCLEOTIDE SEQUENCE BIAS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA STABILITY; RNA TRANSPORT; VIRUS GENE; WILD TYPE; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 8;

GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; RNA, VIRAL; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 84928559683     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03264-14     Document Type: Article

References (70)

1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869. http://dx.doi.org/10.1126/science.7997879.
2. Damania B. 2004. Oncogenic gammaherpesviruses: comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol 2:656-668. http://dx.doi.org/10.1038/nrmicro958.
3. Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J Clin Invest 120:939-949. http://dx.doi.org/10.1172/JCI40567.
4. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1:273-296. http://dx.doi.org/10.1146/annurev.pathol.1.110304.100133.
5. Schulz TF. 2006. The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 208:187-198. http://dx.doi.org/10.1002/path.1904.
6. Le Hir H, Gatfield D, Izaurralde E, Moore MJ. 2001. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. EMBO J 20:4987-4997. http://dx.doi.org/10.1093/emboj/20.17.4987.
7. Le Hir H, Izaurralde E, Maquat LE, Moore MJ. 2000. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exonexon junctions. EMBO J 19:6860-6869. http://dx.doi.org/10.1093/emboj/19.24.6860.
8. Nino CA, Herissant L, Babour A, Dargemont C. 2013. mRNA nuclear export in yeast. Chem Rev 113:8523-8545. http://dx.doi.org/10.1021/cr400002g.
9. Cullen BR. 2003. Nuclear mRNA export: insights from virology. Trends Biochem Sci 28:419-424. http://dx.doi.org/10.1016/S0968-0004(03)00142-7.
10. Gatfield D, Izaurralde E. 2002. REF1/Aly and the additional exon junction complex proteins are dispensable for nuclear mRNA export. J Cell Biol 159:579-588. http://dx.doi.org/10.1083/jcb.200207128.
11. Gatfield D, Le Hir H, Schmitt C, Braun IC, Kocher T, Wilm M, Izaurralde E. 2001. The DExH/D box protein HEL/UAP56 is essential for mRNA nuclear export in Drosophila. Curr Biol 11:1716-1721. http://dx.doi.org/10.1016/S0960-9822(01)00532-2.
12. Herold A, Klymenko T, Izaurralde E. 2001. NXF1/p15 heterodimers are essential for mRNA nuclear export in Drosophila. RNA 7:1768-1780.
13. Luo ML, Zhou Z, Magni K, Christoforides C, Rappsilber J, Mann M, Reed R. 2001. Pre-mRNA splicing and mRNA export linked by direct interactions between UAP56 and Aly. Nature 413:644-647. http://dx.doi.org/10.1038/35098106.
14. Stutz F, Bachi A, Doerks T, Braun IC, Seraphin B, Wilm M, Bork P, Izaurralde E. 2000. REF, an evolutionary conserved family of hnRNP-like proteins, interacts with TAP/Mex67p and participates in mRNA nuclear export. RNA 6:638-650. http://dx.doi.org/10.1017/S1355838200000078.
15. Wiegand HL, Coburn GA, Zeng Y, Kang Y, Bogerd HP, Cullen BR. 2002. Formation of Tap/NXT1 heterodimers activates Tap-dependent nuclear mRNA export by enhancing recruitment to nuclear pore complexes. Mol Cell Biol 22:245-256. http://dx.doi.org/10.1128/MCB.22.1.245-256.2002.
16. Grzybowska EA. 2012. Human intronless genes: functional groups, associated diseases, evolution, and mRNA processing in absence of splicing. Biochem Biophys Res Commun 424:1-6. http://dx.doi.org/10.1016/j.bbrc.2012.06.092.
17. Zheng ZM. 2003. Split genes and their expression in Kaposi's sarcomaassociated herpesvirus. Rev Med Virol 13:173-184. http://dx.doi.org/10.1002/rmv.387.
18. Le Hir H, Nott A, Moore MJ. 2003. How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci 28:215-220. http://dx.doi.org/10.1016/S0968-0004(03)00052-5.
19. Reed R, Hurt E. 2002. A conserved mRNA export machinery coupled to pre-mRNA splicing. Cell 108:523-531. http://dx.doi.org/10.1016/S0092-8674(02)00627-X.
20. Sandri-Goldin RM. 2008. The many roles of the regulatory protein ICP27 during herpes simplex virus infection. Front Biosci 13:5241-5256.
21. Malik P, Blackbourn DJ, Clements JB. 2004. The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor. J Biol Chem 279: 33001-33011. http://dx.doi.org/10.1074/jbc. M313008200.
22. Toth Z, Stamminger T. 2008. The human cytomegalovirus regulatory protein UL69 and its effect on mRNA export. Front Biosci 13:2939-2949. http://dx.doi.org/10.2741/2899.
23. Boyne JR, Colgan KJ, Whitehouse A. 2008. Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication. PLoS Pathog 4:e1000194. http://dx.doi.org/10.1371/journal.ppat.1000194.
24. Jackson BR, Boyne JR, Noerenberg M, Taylor A, Hautbergue GM, Walsh MJ, Wheat R, Blackbourn DJ, Wilson SA, Whitehouse A. 2011. An interaction between KSHV ORF57 and UIF provides mRNA-adaptor redundancy in herpesvirus intronless mRNA export. PLoS Pathog 7:e1002138. http://dx.doi.org/10.1371/journal.ppat.1002138.
25. Nekorchuk M, Han Z, Hsieh TT, Swaminathan S. 2007. Kaposi's sarcoma-associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export. J Virol 81:9990-9998. http://dx.doi.org/10.1128/JVI.00896-07.
26. Stubbs SH, Hunter OV, Hoover A, Conrad NK. 2012. Viral factors reveal a role for REF/Aly in nuclear RNA stability. Mol Cell Biol 32:1260-1270. http://dx.doi.org/10.1128/MCB.06420-11.
27. Sun R, Lin SF, Gradoville L, Miller G. 1996. Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 93:11883-11888. http://dx.doi.org/10.1073/pnas.93.21.11883.
28. Majerciak V, Lu M, Li X, Zheng ZM. 2014. Attenuation of the suppressive activity of cellular splicing factor SRSF3 by Kaposi sarcoma-associated herpesvirus ORF57 protein is required for RNA splicing. RNA 20:1747-1758. http://dx.doi.org/10.1261/rna.045500.114.
29. Majerciak V, Yamanegi K, Allemand E, Kruhlak M, Krainer AR, Zheng ZM. 2008. Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing. J Virol 82:2792-2801. http://dx.doi.org/10.1128/JVI.01856-07.
30. Boyne JR, Jackson BR, Taylor A, Macnab SA, Whitehouse A. 2010. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs. EMBO J 29:1851-1864. http://dx.doi.org/10.1038/emboj.2010.77.
31. Diem MD, Chan CC, Younis I, Dreyfuss G. 2007. PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of spliced mRNAs. Nat Struct Mol Biol 14:1173-1179. http://dx.doi.org/10.1038/nsmb1321.
32. Malik P, Blackbourn DJ, Cheng MF, Hayward GS, Clements JB. 2004. Functional co-operation between the Kaposi's sarcoma-associated herpesvirus ORF57 and ORF50 regulatory proteins. J Gen Virol 85:2155-2166. http://dx.doi.org/10.1099/vir.0.79784-0.
33. Jackson BR, Noerenberg M, Whitehouse A. 2014. A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus-infected cells. PLoS Pathog 10:e1004098. http://dx.doi.org/10.1371/journal.ppat.1004098.
34. Schumann S, Jackson BR, Baquero-Perez B, Whitehouse A. 2013. Kaposi's sarcoma-associated herpesvirus ORF57 protein: exploiting all stages of viral mRNA processing. Viruses 5:1901-1923. http://dx.doi.org/10.3390/v5081901.
35. Kang JG, Pripuzova N, Majerciak V, Kruhlak M, Le SY, Zheng ZM. 2011. Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppression. J Virol 85:2620-2630. http://dx.doi.org/10.1128/JVI.02144-10.
36. Massimelli MJ, Kang JG, Majerciak V, Le SY, Liewehr DJ, Steinberg SM, Zheng ZM. 2011. Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1. Int J Biol Sci 7:1145-1160.
37. Sei E, Conrad NK. 2011. Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity. Virology 419:107-116. http://dx.doi.org/10.1016/j.virol.2011.08.006.
38. Majerciak V, Yamanegi K, Nie SH, Zheng ZM. 2006. Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J Biol Chem 281:28365-28378. http://dx.doi.org/10.1074/jbc. M603095200.
39. Majerciak V, Zheng ZM. 2009. Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing. Front Biosci (Landmark ed) 14:1516-1528.
40. Jackson BR, Noerenberg M, Whitehouse A. 2012. The Kaposi's sarcomaassociated herpesvirus ORF57 protein and its multiple roles in mRNA biogenesis. Front Microbiol 3:59. http://dx.doi.org/10.3389/fmicb.2012.00059.
41. Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ. 2002. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 76:6185-6196. http://dx.doi.org/10.1128/JVI.76.12.6185-6196.2002.
42. Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, Schulz TF. 2006. Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4-and BRD2/RING3-induced G1 cell cycle arrest. J Virol 80:10772-10786. http://dx.doi.org/10.1128/JVI.00804-06.
43. Wodrich H, Bohne J, Gumz E, Welker R, Krausslich HG. 2001. A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression. J Virol 75:10670-10682. http://dx.doi.org/10.1128/JVI.75.22.10670-10682.2001.
44. Graf M, Ludwig C, Kehlenbeck S, Jungert K, Wagner R. 2006. A quasi-lentiviral green fluorescent protein reporter exhibits nuclear export features of late human immunodeficiency virus type 1 transcripts. Virology 352:295-305. http://dx.doi.org/10.1016/j.virol.2006.05.001.
45. Gabaev I, Steinbruck L, Pokoyski C, Pich A, Stanton RJ, Schwinzer R, Schulz TF, Jacobs R, Messerle M, Kay-Fedorov PC. 2011. The human cytomegalovirus UL11 protein interacts with the receptor tyrosine phosphatase CD45, resulting in functional paralysis of T cells. PLoS Pathog 7:e1002432. http://dx.doi.org/10.1371/journal.ppat.1002432.
46. Zychlinski D, Erkelenz S, Melhorn V, Baum C, Schaal H, Bohne J. 2009. Limited complementarity between U1 snRNA and a retroviral 5' splice site permits its attenuation via RNA secondary structure. Nucleic Acids Res 37:7429-7440. http://dx.doi.org/10.1093/nar/gkp694.
47. Kati S, Tsao EH, Gunther T, Weidner-Glunde M, Rothamel T, Grundhoff A, Kellam P, Schulz TF. 2013. Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells. J Virol 87:8004-8016. http://dx.doi.org/10.1128/JVI.00506-13.
48. Haas DA, Bala K, Busche G, Weidner-Glunde M, Santag S, Kati S, Gramolelli S, Damas M, Dittrich-Breiholz O, Kracht M, Ruckert J, Varga Z, Keri G, Schulz TF. 2013. The inflammatory kinase MAP4K4 promotes reactivation of Kaposi's sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells. PLoS Pathog 9:e1003737. http://dx.doi.org/10.1371/journal.ppat.1003737.
49. Brinkmann MM, Glenn M, Rainbow L, Kieser A, Henke-Gendo C, Schulz TF. 2003. Activation of mitogen-activated protein kinase and NF-κB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J Virol 77:9346-9358. http://dx.doi.org/10.1128/JVI.77.17.9346-9358.2003.
50. Paz I, Kosti I, Ares M, Jr, Cline M, Mandel-Gutfreund Y. 2014. RBPmap: a web server for mapping binding sites of RNA-binding proteins. Nucleic Acids Res 42:W361-W367. http://dx.doi.org/10.1093/nar/gku406.
51. Brinkmann MM, Pietrek M, Dittrich-Breiholz O, Kracht M, Schulz TF. 2007. Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus. J Virol 81:42-58. http://dx.doi.org/10.1128/JVI.00648-06.
52. Bilello JP, Morgan JS, Desrosiers RC. 2008. Extreme dependence of gH and gL expression on ORF57 and association with highly unusual codon usage in rhesus monkey rhadinovirus. J Virol 82:7231-7237. http://dx.doi.org/10.1128/JVI.00564-08.
53. Pilkington GR, Majerciak V, Bear J, Uranishi H, Zheng ZM, Felber BK. 2012. Kaposi's sarcoma-associated herpesvirus ORF57 is not a bona fide export factor. J Virol 86:13089-13094. http://dx.doi.org/10.1128/JVI.00606-12.
54. Wagner R, Graf M, Bieler K, Wolf H, Grunwald T, Foley P, Uberla K. 2000. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther 11:2403-2413. http://dx.doi.org/10.1089/104303400750038507.
55. Fornerod M, Ohno M, Yoshida M, Mattaj IW. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060. http://dx.doi.org/10.1016/S0092-8674(00)80371-2.
56. Gruter P, Tabernero C, von Kobbe C, Schmitt C, Saavedra C, Bachi A, Wilm M, Felber BK, Izaurralde E. 1998. TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol Cell 1:649-659. http://dx.doi.org/10.1016/S1097-2765(00)80065-9.
57. Iacampo S, Cochrane A. 1996. Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA. J Virol 70:8332-8339.
58. Zolotukhin AS, Valentin A, Pavlakis GN, Felber BK. 1994. Continuous propagation of RRE(-) and Rev(-) RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J Virol 68: 7944-7952.
59. Graf M, Bojak A, Deml L, Bieler K, Wolf H, Wagner R. 2000. Concerted action of multiple cis-acting sequences is required for Rev dependence of late human immunodeficiency virus type 1 gene expression. J Virol 74: 10822-10826. http://dx.doi.org/10.1128/JVI.74.22.10822-10826.2000.
60. Bala K, Bosco R, Gramolelli S, Haas DA, Kati S, Pietrek M, Havemeier A, Yakushko Y, Singh VV, Dittrich-Breiholz O, Kracht M, Schulz TF. 2012. Kaposi's sarcoma herpesvirus K15 protein contributes to virusinduced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression. PLoS Pathog 8:e1002927. http://dx.doi.org/10.1371/journal.ppat.1002927.
61. Shin YC, Desrosiers RC. 2011. Rhesus monkey rhadinovirus ORF57 induces gH and gL glycoprotein expression through posttranscriptional accumulation of target mRNAs. J Virol 85:7810-7817. http://dx.doi.org/10.1128/JVI.00493-11.
62. Schneider R, Campbell M, Nasioulas G, Felber BK, Pavlakis GN. 1997. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J Virol 71:4892-4903.
63. Nawroth I, Mueller F, Basyuk E, Beerens N, Rahbek UL, Darzacq X, Bertrand E, Kjems J, Schmidt U. 2014. Stable assembly of HIV-1 export complexes occurs cotranscriptionally. RNA 20:1-8. http://dx.doi.org/10.1261/rna.038182.113.
64. Kofman A, Graf M, Deml L, Wolf H, Wagner R. 2003. Codon usagemediated inhibition of HIV-1 gag expression in mammalian cells occurs independently of translation. Tsitologiia 45:94-100.
65. Wodrich H, Schambach A, Krausslich HG. 2000. Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. Nucleic Acids Res 28:901-910. http://dx.doi.org/10.1093/nar/28.4.901.
66. Santag S, Jager W, Karsten CB, Kati S, Pietrek M, Steinemann D, Sarek G, Ojala PM, Schulz TF. 2013. Recruitment of the tumour suppressor protein p73 by Kaposi's sarcoma herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells. Oncogene 32:3676-3685. http://dx.doi.org/10.1038/onc.2012.385.
67. Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF. 2006. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog 2:e68. http://dx.doi.org/10.1371/journal.ppat.0020068.
68. Bohne J, Wodrich H, Krausslich HG. 2005. Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end. Nucleic Acids Res 33:825-837. http://dx.doi.org/10.1093/nar/gki185.
69. Malik P, Clements JB. 2004. Protein kinase CK2 phosphorylation regulates the interaction of Kaposi's sarcoma-associated herpesvirus regulatory protein ORF57 with its multifunctional partner hnRNP K Nucleic Acids Res 32:5553-5569.
70. Nishimura K, Ueda K, Guwanan E, Sakakibara S, Do E, Osaki E, Yada K, Okuno T, Yamanishi K. 2004. A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES. Virology 325:364-378. http://dx.doi.org/10.1016/j.virol.2004.04.041.